Sensorion SA (ALSEN) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.332x

Based on the latest financial reports, Sensorion SA (ALSEN) has a cash flow conversion efficiency ratio of -0.332x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-18.94 Million ≈ $-22.14 Million USD) by net assets (€56.98 Million ≈ $66.61 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Sensorion SA - Cash Flow Conversion Efficiency Trend (2012–2024)

This chart illustrates how Sensorion SA's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read ALSEN total liabilities for a breakdown of total debt and financial obligations.

Sensorion SA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Sensorion SA ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Trabzonspor Sportif Yatirim ve Futbol Isletmeciligi Ticaret AS IS:TSPOR	0.651x
Omaxe Limited NSE:OMAXE	0.104x
Prospector Metals Corp V:PPP	-0.492x
Kartonsan Karton Sanayi ve Ticaret AS IS:KARTN	-0.074x
Cho Kwang Leat KO:004700	0.010x
Terra Santa Propriedades Agrícolas S.A. SA:LAND3	0.070x
Xerox Corp NASDAQ:XRX	0.496x
Hsing Ta Cement Co Ltd TW:1109	0.005x

Annual Cash Flow Conversion Efficiency for Sensorion SA (2012–2024)

The table below shows the annual cash flow conversion efficiency of Sensorion SA from 2012 to 2024. For the full company profile with market capitalisation and key ratios, see Sensorion SA stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€72.14 Million ≈ $84.34 Million	€-21.33 Million ≈ $-24.94 Million	-0.296x	+53.30%
2023-12-31	€33.28 Million ≈ $38.90 Million	€-21.07 Million ≈ $-24.63 Million	-0.633x	+35.30%
2022-12-31	€21.87 Million ≈ $25.57 Million	€-21.41 Million ≈ $-25.02 Million	-0.979x	-299.56%
2021-12-31	€43.98 Million ≈ $51.42 Million	€-10.77 Million ≈ $-12.59 Million	-0.245x	-168.93%
2020-12-31	€58.35 Million ≈ $68.21 Million	€-5.31 Million ≈ $-6.21 Million	-0.091x	+91.51%
2019-12-31	€13.21 Million ≈ $15.45 Million	€-14.17 Million ≈ $-16.56 Million	-1.072x	+69.27%
2018-12-31	€3.51 Million ≈ $4.10 Million	€-12.25 Million ≈ $-14.32 Million	-3.489x	-228.29%
2017-12-31	€7.32 Million ≈ $8.56 Million	€-7.78 Million ≈ $-9.10 Million	-1.063x	-26.94%
2016-12-31	€8.59 Million ≈ $10.04 Million	€-7.19 Million ≈ $-8.41 Million	-0.837x	-112.45%
2015-12-31	€12.82 Million ≈ $14.99 Million	€-5.05 Million ≈ $-5.91 Million	-0.394x	-105.53%
2014-12-31	€-323.20K ≈ $-377.85K	€-2.30 Million ≈ $-2.69 Million	7.130x	+504.41%
2013-12-31	€-1.20 Million ≈ $-1.40 Million	€-1.42 Million ≈ $-1.66 Million	1.180x	+103.73%
2012-12-31	€26.11K ≈ $30.53K	€-826.03K ≈ $-965.71K	-31.636x	--

About Sensorion SA

PA:ALSEN France Biotechnology

Market Cap

$243.07 Million

€207.91 Million EUR

Market Cap Rank

#17225 Global

#257 in France

Share Price

€0.40

Change (1 day)

+10.23%

52-Week Range

€0.28 - €0.70

All Time High

€12.53